
GWJ-A-23
CAS No. 1351930-95-4
GWJ-A-23( GWJ-23 | GWJ23 )
Catalog No. M11425 CAS No. 1351930-95-4
GWJ-A-23 (GWJ-23, GWJ23) is a?potent, selective autotaxin inhibitor with Ki of 18 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameGWJ-A-23
-
NoteResearch use only, not for human use.
-
Brief DescriptionGWJ-A-23 (GWJ-23, GWJ23) is a?potent, selective autotaxin inhibitor with Ki of 18 nM.
-
DescriptionGWJ-A-23 (GWJ-23, GWJ23) is a?potent, selective autotaxin inhibitor with Ki of 18 nM, an analog of the known ATX inhibitor S32826 and has improved aqueous solubility compared with the parent compound; reduces lung collagen, bronchoalveolar lavage cell counts, total protein, LPA, and TGF-β levels, attenuates the pathogenesis of pulmonary fibrosis in vivo.
-
In Vitro——
-
In Vivo——
-
SynonymsGWJ-23 | GWJ23
-
PathwayWnt/Notch/Hedgehog
-
TargetAutotaxin
-
RecptorAutotaxin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1351930-95-4
-
Formula Weight385.14
-
Molecular FormulaC17H28NO4P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCCCCCCC(=O)NC1=CC=C(C=C1)CP(=O)([O-])[O-].[Na+].[Na+]
-
Chemical Name4-(decanoylamino)benzyl]phosphonic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jiang G, et al. Bioorg Med Chem Lett. 2011 Sep 1;21(17):5098-101.
molnova catalog



related products
-
Autotaxin inhibitor ...
Autotaxin inhibitor compound 1 (Autotaxin-IN-1) is a potent, selective, orally bioavailable inhibitor of autotaxin with IC50 of 2.2 nM in ex vivo human whole blood assay.
-
PAT-505
PAT-505 (PAT 505, PAT505) is a potent, selective, noncompetitive, and orally active autotaxin inhibitor with IC50 of 2.0 nM against the lysoPLD activity of human ATX.
-
PAT-048
PAT-048 (PAT048) is a?potent, selective, noncompetitive autotaxin inhibitor with IC50 of 1.1 nM against the lysoPLD activity of human ATX.